IL46690A - Pharmaceutical compositions containing &-(2,2-dialkyl propanolyl)toluene derivatives - Google Patents

Pharmaceutical compositions containing &-(2,2-dialkyl propanolyl)toluene derivatives

Info

Publication number
IL46690A
IL46690A IL46690A IL4669075A IL46690A IL 46690 A IL46690 A IL 46690A IL 46690 A IL46690 A IL 46690A IL 4669075 A IL4669075 A IL 4669075A IL 46690 A IL46690 A IL 46690A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
composition according
formula
compound
dosage form
Prior art date
Application number
IL46690A
Other languages
English (en)
Other versions
IL46690A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL46690A0 publication Critical patent/IL46690A0/xx
Publication of IL46690A publication Critical patent/IL46690A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL46690A 1974-02-25 1975-02-24 Pharmaceutical compositions containing &-(2,2-dialkyl propanolyl)toluene derivatives IL46690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44526574A 1974-02-25 1974-02-25
US49586274A 1974-08-08 1974-08-08

Publications (2)

Publication Number Publication Date
IL46690A0 IL46690A0 (en) 1975-04-25
IL46690A true IL46690A (en) 1977-07-31

Family

ID=27034241

Family Applications (1)

Application Number Title Priority Date Filing Date
IL46690A IL46690A (en) 1974-02-25 1975-02-24 Pharmaceutical compositions containing &-(2,2-dialkyl propanolyl)toluene derivatives

Country Status (8)

Country Link
AU (1) AU500550B2 (enExample)
CA (1) CA1041909A (enExample)
DE (1) DE2506456A1 (enExample)
FR (1) FR2261758B1 (enExample)
GB (1) GB1504207A (enExample)
IE (1) IE40941B1 (enExample)
IL (1) IL46690A (enExample)
NL (1) NL7502079A (enExample)

Also Published As

Publication number Publication date
IE40941L (en) 1975-08-25
NL7502079A (nl) 1975-08-27
AU500550B2 (en) 1979-05-24
GB1504207A (en) 1978-03-15
DE2506456A1 (de) 1975-08-28
AU7854575A (en) 1976-08-26
FR2261758A1 (enExample) 1975-09-19
IE40941B1 (en) 1979-09-12
FR2261758B1 (enExample) 1980-01-11
IL46690A0 (en) 1975-04-25
CA1041909A (en) 1978-11-07

Similar Documents

Publication Publication Date Title
KR910004572B1 (ko) 경구용 당뇨병 치료제 제형의 제조방법
EP0309157B1 (en) Sustained release etodolac
CA2238553C (en) Cholesterol-lowering composition
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
KR20010007332A (ko) 신속하게 흡수되는 액제 조성물
JPH0640928A (ja) アントシアノシド類を含有する経口医薬組成物
EP0373507A1 (en) Combination of an HMG CoA reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
US4233317A (en) Analgesic potentiation
KR960007753B1 (ko) 피페리디노알칸올 유도체용 제약 조성물
JP2002249431A (ja) トリグリセリド低下剤組成物
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
EP0190851B1 (en) Improved antiinflammatory composition
JPH0140009B2 (enExample)
CA1041909A (en) Pharmaceutical composition containing p-alkanoyltoluene
US5504105A (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
JPH07103019B2 (ja) 胃炎治療・予防剤
US4175128A (en) Method for treating congestive heart failure
US3968247A (en) Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents
Nitsch et al. Increase of mexiletine plasma levels due to delayed hepatic metabolism in patients with chronic liver disease
US3941888A (en) Substituted or unsubstituted p-alkanoyl toluenes as hypolipidemics
US3924003A (en) Substituted or unsubstituted p-alkanoyl toluenes as anti-obesity and anti-diabetic agents
CA1048934A (en) Organic compounds
JPH0687750A (ja) 医薬組成物
US3821381A (en) Method of treatment
US3798322A (en) 6 or 7-substituted 4 or 8-(amino-1-methyl-butylamino)quinolines as hypolipidemic agents